# MediMind — Stage 2 Diabetes Shadow Status Report

**Document Version:** 1.0.0  
**Effective Date:** October 19, 2026  
**Evaluation Stage:** Stage 2 Pre-Evaluation Readiness  
**Current Operating State:** **PRE-EVALUATION READINESS (SHADOW-READY)**  
**Runtime Enablement Flag:** `ENABLE_DIABETES_SHADOW_EVAL=false` (Default, Dormant)  
**Governance Reference:** MM-AI-STAT-2026-DIAB-SHADOW-03  

---

## 1. Executive Status & Truth in Advertising Declaration

As of October 19, 2026, the Stage 2 Diabetes Shadow Evaluation framework has been fully engineered, validated via comprehensive automated unit/integration suites, and packaged with strict fail-safe isolation.

> [!IMPORTANT]
> **Definitive Status Declaration:**
> The system is currently in **PRE-EVALUATION READINESS (SHADOW-READY)** status.
> - **Total Live Prospective Inferences Evaluated:** Exactly **0**.
> - **Completed Evaluation Duration:** **0 days** of the target 30-day window.
> - **Adjudicated Clinical Outcomes:** Exactly **0**.
> - No claim of prospective clinical validation is made or implied. The shadow evaluation engine is intentionally dormant (`ENABLE_DIABETES_SHADOW_EVAL=false`) until formal clinical sign-off is granted.

---

## 2. Cryptographic Integrity & Production Immutability Verification

All baseline production model weights, preprocessing pipelines, and inference services were independently audited via SHA-256 cryptographic hashing before and after the staging and shadow service integration. Zero bytes of production assets have been modified.

### 2.1 Production Artifacts (100% Unchanged)
| Production Artifact | File Path | Baseline SHA-256 Hash | Post-Implementation SHA-256 Hash | Verification Status |
| :--- | :--- | :--- | :--- | :--- |
| **Diabetes Production Model** | `artifacts/diabetes/best_model.joblib` | `65a15bf8674d01ce714033acd38744dc023211c53bcf7f1521fcaf3ab0756af9` | `65a15bf8674d01ce714033acd38744dc023211c53bcf7f1521fcaf3ab0756af9` | **IDENTICAL (VERIFIED)** |
| **Heart Disease Production Model**| `artifacts/heart_disease/best_model.joblib` | `1651a506476606ae6e8a4b33ed2edded6181d5917b019287c62f43cdb812ef2c` | `1651a506476606ae6e8a4b33ed2edded6181d5917b019287c62f43cdb812ef2c` | **IDENTICAL (VERIFIED)** |
| **Diabetes Production Service** | `app/services/diabetes_service.py` | `1d8af27e821ef49177e3295096483d50fa8248a59032b6284c72ba1f1399e268` | `1d8af27e821ef49177e3295096483d50fa8248a59032b6284c72ba1f1399e268` | **IDENTICAL (VERIFIED)** |
| **Heart Disease Production Service**| `app/services/heart_disease_service.py` | `678da749c49d5c19937a417e9ffc193d4b0a937308bc6b3987a3392cebf7a3f2` | `678da749c49d5c19937a417e9ffc193d4b0a937308bc6b3987a3392cebf7a3f2` | **IDENTICAL (VERIFIED)** |

### 2.2 Shadow Candidate Artifacts
| Candidate Artifact | File Path | Registered SHA-256 Hash | Status |
| :--- | :--- | :--- | :--- |
| **Candidate C (Deep MLP)** | `artifacts/experiments/benchmark_four_approaches_20261019/diabetes_appC_mlp_6layer_bottleneck_gelu.joblib` | `26b3a2ae31a19f4a0c84138e6dfd15ee6a17b2b6c7ce1a5401bb26400dbb6be0` | **REGISTERED & STAGED** |
| **Candidate A (ExtraTrees)** | `artifacts/experiments/benchmark_four_approaches_20261019/diabetes_appA_extratrees.joblib` | `c0fe202b2de047cb56247fb0dbe422c5e5aa495f2a1b948dc2a046ce59ec47b5` | **REGISTERED & STAGED** |
| **Training Imputation Medians** | `artifacts/experiments/benchmark_four_approaches_20261019/training_medians.joblib` | `4a49646452288924b1ae1d62c1257410c55fbcbe4bcfa2763f91ba40a7cf3957` | **REGISTERED & STAGED** |

---

## 3. Pre-Deployment Automated Test Verification

Full test suite execution was performed on the active branch (`experiment8-multiview-localized-fusion`) using pytest on Python 3.14.8:

### 3.1 New Shadow & Staging Unit/Integration Tests
File: `tests/diabetes/test_shadow_diabetes_service.py` & `test_staging_diabetes_service.py`
- `test_shadow_service_disabled_by_default`: **PASSED**
- `test_shadow_service_executes_both_candidates_when_enabled`: **PASSED**
- `test_shadow_service_records_unauthorized_scope_exclusion`: **PASSED**
- `test_shadow_service_adjudication_and_metrics_calculation`: **PASSED**
- `test_shadow_service_handles_candidate_failure_gracefully`: **PASSED**
- `test_staging_service_loads_and_predicts_all_candidates`: **PASSED**
- `test_staging_service_rejects_unknown_candidate`: **PASSED**
- `test_staging_service_schema_rejects_infinite_input`: **PASSED**
**Subtotal: 8 passed / 8 total (100.0%)**

### 3.2 Full Regression Test Suite
Execution of all test modules across `tests/heart_disease` and `tests/diabetes`:
- Total Tests: **55**
- Passed: **55**
- Failed: **0**
- Errors: **0**
- Regressions: **0**

---

## 4. Current Baseline Accounting Ledger

The initial accounting ledger stands in initialized pre-evaluation state:

```json
{
  "total_requests": 0,
  "eligible_requests": 0,
  "shadow_evaluated_requests": 0,
  "failed_requests": 0,
  "invalid_schema_requests": 0,
  "excluded_requests": 0,
  "daily_counts": {},
  "target_sample_size": 500,
  "target_duration_days": 30,
  "completion_percentage": 0.0
}
```

---

## 5. Open Blockers & Prerequisites to Activation

Before setting `ENABLE_DIABETES_SHADOW_EVAL=true` in production, the following governance prerequisites must be fulfilled:

1. **CMO Clinical Protocol Sign-Off:** Formal written review and sign-off of `MediMind_Diabetes_Shadow_Evaluation_Protocol.md` by the Chief Medical Officer.
2. **Key Escrow Initialization:** Creation of the secure offline key escrow mapping table for prospective adjudication linkage.
3. **Institutional Review Board (IRB) / Privacy Officer Approval:** Confirmation that SHA-256 pseudonymized shadow logging satisfies clinical data minimization policies.
4. **Monitoring Dashboard Ingestion:** Configuration of Prometheus/Grafana alerts on the `shadow_accounting_ledger.json` error counter.
